Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nanospectra Biosciences Inc.

Latest From Nanospectra Biosciences Inc.

Start-Up News

Noteworthy news from medtech start-ups. This month we profile Nanospectra Biosciences and its near-infrared tumor ablation technology; Vertos Medical, which is developing "ultra" minimally invasive technology for treating spinal stenosis; and Freedom Meditech's noninvasive ophthalmic glucose monitoring technology.
Medical Device

Nanobiotix SA

Nanobiotix is taking advantage of the ability of nanoparticles to absorb and transform energy to treat cancer. The company's nanoXray technology uses standard x-ray to activate injected cell-targeting non-drug nanoparticles. Today, Nanobiotix is focused solely on cancer applications of its technology, but the company believes there are other targets for the technology, including cardiovascular diseases.
BioPharmaceutical Medical Device

Start-Up Previews (2/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Small Size=Big Potential , features profiles of C Sixty Inc., engeneOS Inc., Nanospectra Biosciences Inc. and Oxonica Ltd., Plus these Selected Start-Ups across Health Care: Addiction Therapies Inc., ImpactRx Inc., Ingenium Pharmaceuticals AG and Insulet Corp.

Nanospectra Biosciences Inc.

Nanospectra Biosciences multipurpose Nanoshell platform utilizes a novel class of materials that absorb or scatter light at desired wavelengths. Nanoshells can be used to destroy cancer cells by absorbing thermal energy, for tissue welding, as a drug delivery technology, or as a diagnostic to rapidly detect the presence of antigens in whole blood.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nanospectra Biosciences Inc.
  • Senior Management
  • John Stroh, Pres. & CEO
  • Contact Info
  • Nanospectra Biosciences Inc.
    Phone: (713) 842-2720
    8285 El Rio St.
    Suite 130
    Houston, TX 77054